PODD vs. RMD: Insulet vs. ResMed Stock Comparison
How do Insulet (PODD) and ResMed (RMD) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.
Company Profile
Insulet (PODD) and ResMed (RMD) are both classified in the Health Care Equipment sub-industry within the broader Health Care Equipment & Supplies industry, placing them in the closest GICS peer bucket.
| Profile Item | PODD | RMD |
|---|---|---|
| Name | Insulet Corporation | ResMed Inc. |
| Country/Region | United States | United States |
| GICS Sector | Health Care | Health Care |
| GICS Industry Group | Health Care Equipment & Services | Health Care Equipment & Services |
| GICS Industry | Health Care Equipment & Supplies | Health Care Equipment & Supplies |
| GICS Sub-Industry | Health Care Equipment | Health Care Equipment |
| Market Capitalization | 10.16 billion USD | 33.10 billion USD |
| Currency | USD | USD |
| Exchange | Nasdaq | NYSE |
| Listing Date | May 15, 2007 | June 2, 1995 |
| Security Type | Common Stock | Common Stock |
Price Performance
Cumulative Growth
Trailing Returns
Calendar-Year Returns
Performance Metrics
| Metric | PODD | RMD |
|---|---|---|
| Total Return (1Y) | -53.25% | -5.42% |
| Total Return (3Y, Annualized) | -0.74% | 18.99% |
| Total Return (5Y, Annualized) | -14.02% | -1.23% |
Risk Profile
Drawdown History
Return Distribution
Risk Metrics
| Metric | PODD | RMD |
|---|---|---|
| Volatility (1Y, Annualized) | 46.33% | 30.80% |
| Beta (5Y) | 1.04 | 0.75 |
| Max Drawdown (5Y) | -63.02% | -49.04% |
| Avg. Volume (3M) | 1.58M | 1.32M |
Risk-Adjusted Performance
Risk-Return Positioning
Risk-Adjusted Metrics
| Metric | PODD | RMD |
|---|---|---|
| Sharpe Ratio (1Y) | -1.24 | -0.31 |
| Sortino Ratio (1Y) | -1.51 | -0.43 |
Profitability
ROE (TTM)
Both Insulet (PODD) at 28.94% and ResMed (RMD) at 26.40% sit in the top peer quartile for ROE, suggesting each generates more profit from shareholders’ equity than typical industry peers.
PODD
Health Care Equipment & Services industry group
28.94%
- Max
- 47.61%
- PODD
- 28.94%
- Q3
- 14.36%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
RMD
Health Care Equipment & Services industry group
26.40%
- Max
- 47.61%
- RMD
- 26.40%
- Q3
- 14.36%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
Net Margin (TTM)
For every dollar of sales, both Insulet (PODD) at 13.44% and ResMed (RMD) at 27.79% retain more as net profit than most peers, landing in the top net margin quartile of their industries.
PODD
Health Care Equipment & Services industry group
13.44%
- Max
- 29.35%
- PODD
- 13.44%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
RMD
Health Care Equipment & Services industry group
27.79%
- Max
- 29.35%
- RMD
- 27.79%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
Operating Margin (TTM)
Both Insulet (PODD) at 22.54% and ResMed (RMD) at 34.82% convert sales into operating profit at a top-quartile rate, pointing to tighter cost discipline before financing and tax.
PODD
Health Care Equipment & Services industry group
22.54%
- Max
- 35.43%
- PODD
- 22.54%
- Q3
- 14.14%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
RMD
Health Care Equipment & Services industry group
34.82%
- Max
- 35.43%
- RMD
- 34.82%
- Q3
- 14.14%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
Profitability Metrics
| Metric | PODD | RMD |
|---|---|---|
| ROE (TTM) | 28.94% | 26.40% |
| ROA (TTM) | 11.40% | 14.76% |
| Net Margin (TTM) | 13.44% | 27.79% |
| Operating Margin (TTM) | 22.54% | 34.82% |
| Gross Margin (TTM) | 71.88% | 61.77% |
Growth
Revenue Growth
Insulet (PODD) at 30.73% sits in the top revenue growth quartile, while ResMed (RMD) at 9.85% is closer to the peer norm — faster top-line expansion for PODD.
EPS Growth
Only one side can be read here: Insulet (PODD) reports EPS growth of -39.79%, ranked against its industry; ResMed (RMD) has no EPS growth figure this period.
Growth Metrics
| Metric | PODD | RMD |
|---|---|---|
| Revenue Growth (YoY) | 30.73% | 9.85% |
| Revenue Growth (3Y CAGR) | 27.54% | 10.21% |
| EPS Growth (YoY) | -39.79% | -- |
| EPS Growth (3Y CAGR) | 267.70% | 19.64% |
Financial Strength
Current Ratio (MRQ)
Both Insulet (PODD) at 2.51 and ResMed (RMD) at 2.65 carry current ratio within their industries’ typical mid-ranges, suggesting balanced short-term liquidity relative to peers.
PODD
Health Care Equipment & Services industry group
2.51
- Max
- 7.59
- Q3
- 4.00
- PODD
- 2.51
- Median
- 1.98
- Q1
- 1.37
- Min
- 0.30
RMD
Health Care Equipment & Services industry group
2.65
- Max
- 7.59
- Q3
- 4.00
- RMD
- 2.65
- Median
- 1.98
- Q1
- 1.37
- Min
- 0.30
Debt / Equity (MRQ)
ResMed (RMD) at 0.10 keeps leverage in the lower industry quartile, while Insulet (PODD) at 0.66 runs a more typical debt-to-equity mix.
PODD
Health Care Equipment & Services industry group
0.66
- Max
- 1.88
- Q3
- 0.91
- PODD
- 0.66
- Median
- 0.58
- Q1
- 0.16
- Min
- 0.00
RMD
Health Care Equipment & Services industry group
0.10
- Max
- 1.88
- Q3
- 0.91
- Median
- 0.58
- Q1
- 0.16
- RMD
- 0.10
- Min
- 0.00
Financial Strength Metrics
| Metric | PODD | RMD |
|---|---|---|
| Current Ratio (MRQ) | 2.51 | 2.65 |
| Debt / Equity (MRQ) | 0.66 | 0.10 |
| Net Debt / EBITDA | 0.65 | -0.19 |
Dividends
Dividend Yield (TTM)
Insulet (PODD) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile ResMed (RMD) reports a yield of 1.03%, ranking against industry peers normally.
PODD
Health Care Equipment & Services industry group
0.00%
- PODD
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
RMD
Health Care Equipment & Services industry group
1.03%
- RMD
- 1.03%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Payout Ratio (TTM)
Insulet (PODD) pays no dividend (payout 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile ResMed (RMD) reports a payout of 22.40%, ranking against industry peers normally.
PODD
Health Care Equipment & Services industry group
0.00%
- PODD
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
RMD
Health Care Equipment & Services industry group
22.40%
- RMD
- 22.40%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Metrics
| Metric | PODD | RMD |
|---|---|---|
| Dividend Yield (TTM) | 0.00% | 1.03% |
| Dividend Payout Ratio (TTM) | 0.00% | 22.40% |
Valuation
P/E Ratio (TTM)
Both Insulet (PODD) at 23.94 and ResMed (RMD) at 21.43 land around their industries’ usual P/E ratio levels — neither is getting a clear earnings-multiple discount or premium versus peers.
PODD
Health Care Equipment & Services industry group
23.94
- Max
- 80.41
- Q3
- 47.62
- Median
- 29.93
- PODD
- 23.94
- Q1
- 21.19
- Min
- 4.21
RMD
Health Care Equipment & Services industry group
21.43
- Max
- 80.41
- Q3
- 47.62
- Median
- 29.93
- RMD
- 21.43
- Q1
- 21.19
- Min
- 4.21
P/S Ratio (TTM)
Insulet (PODD) at 3.19 is priced about in line with its industry on P/S ratio, while ResMed (RMD) at 5.77 sits in the pricier quartile — RMD costs more per dollar of sales.
PODD
Health Care Equipment & Services industry group
3.19
- Max
- 8.80
- Q3
- 4.32
- PODD
- 3.19
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
RMD
Health Care Equipment & Services industry group
5.77
- Max
- 8.80
- RMD
- 5.77
- Q3
- 4.32
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
P/B Ratio (MRQ)
ResMed (RMD) at 5.56 is valued about in line with its industry on P/B ratio, while Insulet (PODD) at 6.44 carries an above-peer premium to book — PODD is pricier on assets.
PODD
Health Care Equipment & Services industry group
6.44
- Max
- 11.68
- PODD
- 6.44
- Q3
- 6.12
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
RMD
Health Care Equipment & Services industry group
5.56
- Max
- 11.68
- Q3
- 6.12
- RMD
- 5.56
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
Valuation Metrics
| Metric | PODD | RMD |
|---|---|---|
| P/E Ratio (TTM) | 23.94 | 21.43 |
| P/S Ratio (TTM) | 3.19 | 5.77 |
| P/B Ratio (MRQ) | 6.44 | 5.56 |
| Free Cash Flow Yield (TTM) | 1.12% | 3.92% |